Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pituitary apoplexy
ADR ID BADD_A10689
ADR Hierarchy
05      Endocrine disorders
05.03      Hypothalamus and pituitary gland disorders
05.03.04      Hypothalamic and pituitary disorders NEC
05.03.04.011      Pituitary apoplexy
17      Nervous system disorders
17.08      Central nervous system vascular disorders
17.08.01      Central nervous system haemorrhages and cerebrovascular accidents
17.08.01.072      Pituitary apoplexy
24      Vascular disorders
24.07      Vascular haemorrhagic disorders
24.07.04      Nervous system haemorrhagic disorders
24.07.04.036      Pituitary apoplexy
Description The sudden loss of blood supply to the PITUITARY GLAND, leading to tissue NECROSIS and loss of function (PANHYPOPITUITARISM). The most common cause is hemorrhage or INFARCTION of a PITUITARY ADENOMA. It can also result from acute hemorrhage into SELLA TURCICA due to HEAD TRAUMA; INTRACRANIAL HYPERTENSION; or other acute effects of central nervous system hemorrhage. Clinical signs include severe HEADACHE; HYPOTENSION; bilateral visual disturbances; UNCONSCIOUSNESS; and COMA. [MeSH]
MedDRA Code 10056447
MeSH ID D010899
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Pituitary apoplexy | Pituitary Apoplexy | Apoplexy, Pituitary
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00329Cabergoline0.009609%
BADD_D01136Imatinib0.000504%
BADD_D01260Leuprolide acetate0.002868%
BADD_D02504Lorlatinib0.000112%
The 1th Page    1    Total 1 Pages